Skip to main content
OLIPASS CORPORATION logo

OLIPASS CORPORATION — Investor Relations & Filings

Ticker · 244460 ISIN · KR7244460002 KO Professional, scientific and technical activities
Open in API
Filings indexed 505 across all filing types
Latest filing 2025-05-22 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 244460

About OLIPASS CORPORATION

https://www.olipass.com/front/eng/index…

OLIPASS CORPORATION is a research and development company focused on creating RNA therapeutics. The company's core activities are centered on its proprietary OliPass Peptide Nucleic Acid (OPNA) platform. OPNA is a novel technology derived from Peptide Nucleic Acid (PNA) by introducing a cationic lipid moiety onto the nucleobase. This structural modification is designed to markedly improve cell permeability, a key challenge in nucleic acid-based drug delivery. The platform is optimized to induce exon skipping by specifically binding to target pre-mRNA inside the cell nucleus, enabling the discovery and development of new therapeutic candidates.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Olipass Co., Ltd. regarding a decision on a third-party paid-in capital increase (유상증자결정). It details the amendment of payment dates and listing dates for new shares. This type of filing is a regulatory disclosure concerning capital structure changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2025-05-22 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from Olipass Co., Ltd. regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details the amendment of payment dates and listing dates for a third-party allocation capital increase. This type of filing is a regulatory disclosure concerning changes in capital structure and share issuance, which falls under the 'Share Issue/Capital Change' category.
2025-05-22 Korean
불성실공시법인지정 (공시번복 2건)
Regulatory Filings Classification · 100% confidence The document is an official regulatory notice from the KOSDAQ market regarding the designation of 'Olipass' as an unfaithful disclosure corporation due to disclosure reversals. It details the penalty points, fines, and regulatory grounds for this action. Since this is a specific regulatory announcement regarding compliance and market sanctions that does not fit into financial reporting, M&A, or other specific categories, it is classified as a Regulatory Filing (RNS).
2025-05-16 Korean
주권매매거래정지기간변경 (상장적격성 실질심사 대상(사유발생))
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice regarding the suspension of stock trading for 'Olipass Co., Ltd.' due to a review of listing eligibility. It cites specific exchange regulations (KOSDAQ listing rules) and provides details on the duration of the trading suspension. Since it is a regulatory announcement regarding trading status and does not fit into specific categories like M&A or financial reports, it is classified as a general regulatory filing.
2025-05-16 Korean
기타시장안내 (상장적격성 실질심사 관련 안내)
Regulatory Filings Classification · 100% confidence The document is a short regulatory notice from the KOSDAQ exchange regarding 'Olipass' and its status concerning 'listing eligibility review' (상장적격성 실질심사) due to accumulated penalty points from non-disclosure. This is a formal regulatory announcement regarding the company's listing status and does not fit into specific categories like financial reports or M&A. Therefore, it is classified as a Regulatory Filing (RNS).
2025-05-16 Korean
기타시장안내 (상장적격성 실질심사 대상결정 기한 안내 )
Regulatory Filings Classification · 100% confidence The document is a short notice from the stock exchange regarding the timeline for a 'listing eligibility review' (상장적격성 실질심사) for the company Olipass. It does not contain financial statements, proxy materials, or management reports, but rather serves as a regulatory notification regarding exchange-mandated procedures. Since it does not fit into specific categories like M&A or dividend announcements, it falls under the general regulatory filing category.
2025-05-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.